– CNBC
Peering Into Lam Research’s Recent Short Interest
Lam Research’s (NYSE:LRCX) short percent of float has fallen 10.17% since its last report. The company recently reported…
Related Posts
Scynexis Touts Postive Data For Ibrexafungerp For Vaginal Infections
Scynexis Inc (NASDAQ:SCYX) announced the presentation of positive outcomes from the CANDLE 304s nested sub-study of ibrexafungerp in recurrent vulvovaginal candidiasis…
On Jan 16, Elevai Labs Inc Entered Into A License Agreement With INmune Bio, Inc.; INmune Granted The Co Certain Worldwide Exclusive And Non-Exclusive License Rights To Develop, Manufacture, And Commercialize INmunes’s EMx Technology
- SEC Filing On January 16, 2023, Elevai Labs, Inc., a Delaware corporation (the "Company"), entered into a License Agreement (the "License Agreement") with INmune Bio, Inc., a Nevada corporation ("INmune"). Under
‘#Tim Apple’ Trends on Twitter As Representative Greene Takes A Jibe At Biden For Failing To Recall Her Name
At first glance, the “Tim Apple” trending Twitter hashtag could mislead people to believe that the one who started it may have made an error, apparently wrongly referring to Apple, Inc. (NASDAQ: AAPL) CEO Tim Cook's name.